BCAX
Bicara Therapeutics

75
Loading...
Loading...
News
all
press releases
Bicara Therapeutics (NASDAQ:BCAX) Shares Down 3.3% - Time to Sell?
Bicara Therapeutics (NASDAQ:BCAX) Shares Down 3.3% - Should You Sell...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) CFO Ivan Hyep Sells 605 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 605 shares of the firm's stock in a transaction dated Friday, November 21st. The shares were sold at an average price of...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Insider David Raben Sells 5,500 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) insider David Raben sold 5,500 shares of the company's stock in a transaction on Monday, November 24th. The stock was sold at an average price...
MarketBeat·10d ago
News Placeholder
Claire Mazumdar Sells 41,163 Shares of Bicara Therapeutics (NASDAQ:BCAX) Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CEO Claire Mazumdar sold 41,163 shares of the firm's stock in a transaction on Monday, November 24th. The shares were sold at an average price...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) COO Sells $225,625.00 in Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 12,500 shares of the stock in a transaction dated Friday, November 21st. The stock was sold at an average price of...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) CFO Sells $330,097.25 in Stock
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) CFO Ivan Hyep sold 17,795 shares of Bicara Therapeutics stock in a transaction dated Monday, November 24th. The shares were sold at an average...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) COO Ryan Cohlhepp Sells 12,500 Shares
Bicara Therapeutics Inc. (NASDAQ:BCAX - Get Free Report) COO Ryan Cohlhepp sold 12,500 shares of the firm's stock in a transaction that occurred on Friday, November 21st. The shares were sold at an...
MarketBeat·10d ago
News Placeholder
Bicara Therapeutics (NASDAQ:BCAX) Trading Up 9.5% - Still a Buy?
Bicara Therapeutics (NASDAQ:BCAX) Trading 9.5% Higher - Here's Why...
MarketBeat·15d ago
News Placeholder
Cantor Fitzgerald Analysts Lower Earnings Estimates for BCAX
Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) - Stock analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Bicara Therapeutics in a research note issued on...
MarketBeat·22d ago
News Placeholder
Equities Analysts Issue Forecasts for BCAX FY2025 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) - Research analysts at HC Wainwright lowered their FY2025 earnings per share (EPS) estimates for Bicara Therapeutics in a research report issued...
MarketBeat·22d ago

Latest BCAX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.